Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2022 PharmSci 360 Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Poster Schedule
All Days
Mon, Oct 17
Tue, Oct 18
Wed, Oct 19
Poster Schedule
Type here to filter the list
Wednesday, October 19, 2022
9:30 AM – 10:30 AM
ET
(W0930-01-02) Formulation Development of Enterically Protected Spray Dried Dispersions of Adrulipase
Favorite
9:30 AM – 10:30 AM
ET
(W0930-01-03) Physically- and Chemically-Enhanced Transdermal Delivery of Linagliptin
Favorite
9:30 AM – 10:30 AM
ET
(W0930-01-04) Spray Drying Versus Coprecipitation for Processing Amorphous Solid Dispersions
Favorite
9:30 AM – 10:30 AM
ET
(W0930-01-05) Impact of Spray-Dried Dispersion Formulation and Composition of Physiological Fluid on Micellar and Colloidal Speciation
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-07) Human Retinal Organoids Derived Extracellular Vesicles Loaded with Cannabinoids Attenuates Oxidative Stress Changes in ARPE-19 Cells
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-08) Toxicokinetics of VLX-1005, a Selective Inhibitor of 12-lipoxygenase, following Intravenous Infusion in Rats and Dogs
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-09) Identification of New Novel Biotransformations of Fasiligfam Using cIMS and an Integrated Informatics Workflow
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-11) Anti-inflammatory and Analgesic Effects of a Highly Selective mPGES-1 Inhibitor
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-13) Impact of Film-Coating Excipient Selection on Tablet Performance and Stability
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-14) Macrophage-Specific Nanoparticle Delivery of MicroRNAs to Mitigate Ventilator-Induced Lung Injury during Acute Respiratory Distress Syndrome (ARDS)
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-15) Understanding the Stabilization Mechanism of Polyvinyl Alcohols (Parteck® MXP) in ASDs by Structure-Related Properties and PC-SAFT Modeling
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-16) Comparison of Dialysis and USP-4 Methods to Differentiate Drug Release from Mesalamine Rectal Suppositories
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-17) Functionalized PLGA Nanoparticles Encapsulating Emtricitabine and Bictegravir for Delivery Across the Blood Brain Barrier for the Management of HIV Associated Neurocognitive Disorders (HAND)
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-19) Cisplatin/Hyaluronan Complex: A Novel Loco-Regional Treatment in Tumors Over-Expressing CD44 Receptor
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-20) Comparative Investigation of Albendazole Amorphous Solid Dispersion Prepared by Supercritical Fluid Technology and Hot Melt Extrusion
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-21) Synthesis and Characterization of Functionalized Liposomes Encasing Angiotensin II Receptor shRNA for Management of Neurogenic Hypertension
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-22) Subunit Particulate Vaccine Delivered by Microneedles Elicits Th-1 Skewed Immune Responses Protecting against RSV
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-23) Development and Evaluation of a Drug-in-Adhesive Transdermal Delivery System for Delivery of Olanzapine for Treatment of Schizophrenia and Bipolar Disorder
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-25) Osteoclast Differentiation Is Controlled by KLF2 through the Regulation of Mitochondrial Dysfunction
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-26) Physiologically Based Pharmacokinetic (PBPK) Modeling of Rifampicin and Its Application for Drug-Drug Interaction with Midazolam in Adults
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-27) Pharmacodynamic Assessments of Paclitaxel in Combination with Calcipotriol in Pancreatic Ductal Adenocarcinoma (PDAC)
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-28) LC-MS/MS Method Development and Validation for Evaluation of Brain Pharmacokinetic Parameters of Metformin after an Intravenous Bolus Administration: Application in Ischemic Stroke
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-29) Enhanced U-87 Glioblastoma Cell death by PLGA-PEG Encapsulated Paclitaxel Nanoparticles
Favorite
9:30 AM – 10:30 AM
ET
(W0930-06-32) Applying Quality by Design Principles to the Migration of a Compendial Method between Multiple HPLC Systems
Favorite
9:30 AM – 10:30 AM
ET
(W0930-06-33) Increased Spray Rates for Particulate Coating Using Wurster Pro Technology
Favorite
9:30 AM – 10:30 AM
ET
(W0930-06-34) Explaining Deviant Behaviors in the Tabletability of Mixtures
Favorite
9:30 AM – 10:30 AM
ET
(W0930-06-35) A 3D Printing and Machine Vision Application for Quality Risk Management in Compounding Drug Products at the Point of Need
Favorite
9:30 AM – 10:30 AM
ET
(W0930-07-37) Development of MMP2-Sensitive Carbon Nanotubes for Tumor-Targeted Drug Delivery
Favorite
9:30 AM – 10:30 AM
ET
(W0930-07-38) Sprayed Multi-Adsorbed Droplet Reposing Technology (SMART) for Fabrication of a Protein Drug Delivery System
Favorite
9:30 AM – 10:30 AM
ET
(W0930-07-39) Development of Biodegradable Injectable In Situ Forming Implants for Controlled Release of Cannabinoids: In Ovo Assessment
Favorite
9:30 AM – 10:30 AM
ET
(W0930-07-40) In Vivo Evaluation of Bexarotene Oral Microparticles in Beagle Dogs
Favorite
9:30 AM – 10:30 AM
ET
(W0930-07-41) Nanosuspension Organic Phase Instead of Solution Water Phase: A New Approach to Loading Hydrophilic Trivalent Arsenic Salt with Hydrophobic Polymer
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-43) A Survey of Biological License Application of Monoclonal Antibodies – Part I: Types and Timing of Manufacturing Changes
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-44) Effect of Moderate Biorelevant Increases in Medium Viscosity on the Dissolution Rate of Ibuprofen Particles
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-46) Functionality and Viscosity Influences of Hydroxypropyl Methylcellulose on Wet Granular Processability in a Twin Screw Granulation
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-47) Impact of Change in Test Conditions on Alginate Raft Strength
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-49) Rapid Analysis and Characterization of Lipid Nanoparticle Components for mRNA Delivery
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-50) Development and Validation of a Blood Micro Sampling Methodology to Facilitate Conduct of Pharmacokinetic Studies in Pregnant and Postpartum Patients
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-51) LCMS-MS Method Development and Detection Challenges of low Molecular Weight Hydrophobic Topical Dermatological Products in Support of In Vitro Permeation Testing (IVPT)
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-52) Development and Validation of Chiral HPLC Method for Quantification of L(-) and D(+) Epinephrine in Autoinjectors
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-53) Preclinical Evaluation of Pharmacokinetic, Receptor Occupancy, and Immunogenicity Profiles of a Bispecific Antibody Construct in a Monkey Study
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-55) DNA-Based cGAS Agonists as a Novel Approach to cGAS-STING Activation for Cancer Immunotherapy
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-56) Ethyl Cellulose Coated Polymeric Microneedles for the Controlled Delivery of Drugs
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-57) Biodegradable Electrospun Nanofibrous Scaffolds for Retinal Tissue Engineering: Fabrication and Characterization
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-58) Modulating Host Response to Sepsis via Pure Anti-inflammatory Heparin-Like Compounds
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-59) Intracellular Accumulation and Washout Kinetics of Aminoglycosides (AGS) in Multidrug-Resistant (MDR)
Klebsiella pneumoniae
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-61) Setting up Success in the Clinic through Semi-mechanistic Translational Modelling
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-62) Disposition and Metabolism of [<sup>14</sup>C]-Tirzepatide following Subcutaneous Administration in Healthy Male Participants
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-63) Biorelevant Dissolution and PBPK Modelling to Forecast Oral Absorption – Enabling Formulations for Corallopyronin A
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-64) Using PBPK Modeling in Risk-Assessment of Abuse-Deterrent Formulations
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-67) Release Mechanism and Performance Prediction of a Multi-Block Copolymer-Based Long-Acting Reversible Contraceptive (LARC) Implant
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-68) Development and In Vivo Testing of an Enteric Oral Dosage Form of an Amorphous Solid Dispersion in Beagle Dogs that Generates Amorphous Nanoparticles during Dissolution
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-69) A Single Dose of Nanoparticle Provides 6 Months Efficacy for Preventing Rat Corneal Allograft Rejection
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-70) Novel Sidekick in Vaccine Formulations: Microparticle Autoinducer-1
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-71) 3D Printed Implants for the Treatment of Periprosthetic Joint Infections
Favorite
10:30 AM – 11:30 AM
ET
(W1030-01-01) Formulation Development and In Vitro-Ex Vivo Characterization of Hot-Melt Extruded Ciprofloxacin Hydrochloride Ocular Inserts for Topical Ocular Applications
Favorite
10:30 AM – 11:30 AM
ET
(W1030-01-02) Oral Nano-curcumin Alone or In Combination with Insulin Alleviates Diabetic Neuropathy in Rats
Favorite
10:30 AM – 11:30 AM
ET
(W1030-01-03) Pharmacokinetic and Pharmacodynamic Study of Long-Acting Apixaban Microsphere Injection
Favorite
10:30 AM – 11:30 AM
ET
(W1030-01-05) On Dose Authentication Using Molecular Taggants Applied in a Clear Film Coat
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-14) Development of a Low-Volume In Vitro Dissolution Method for Assessing Variability in Fine Particle Doses of Dry Powder Inhalers
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-16) Comparative Analysis of ‘All-in-One’ Co-processed Excipient Versus Its Proportional Individual Blend in the Production of Vardenafil HCl Tablets via Direction Compression
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-17) Novel Screening Tool for Predicting Mechanical Properties of Filaments Processed via Hot Melt Extrusion
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-18) Palatable Tamoxifen Rodent Diet: An Innovative Administration Method in Mice to Achieve Inducible Cre Recombinase
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-19) Inhalable Dry Powder Formulation of PLGA Microparticles Loaded with Clofazimine for Treatment of Tuberculosis
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-20) Evaluation of In Vitro Performance Attributes of Imvexxy® (Estradiol) Vaginal Insert
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-21) Design of Amorphous Solid Dispersions for the Synchronized Release of Two Drugs
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-22) Hispolon Cyclodextrin Complexes and Cyclodextrins-in-Liposomes for Enhanced In Vitro Anticancer Activity against Melanoma
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-23) ELC-Cu Nanoparticles Induce Cell Death by Mediating Mitochondria Oxidative Stress and Trigger an Innate Immune Response for Cancer Therapy
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-25) CD133-Positive Dermal Papilla Cells are a Major Driver of Hair Follicle Neogenesis
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-26) Studying the Effect of Increased Modifier Range on EPSA Analysis by SFC
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-27) Optimization of Spray-Drying Parameters for Formulation Development at Preclinical Scale
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-28) Effects of B4GALNT1 Expression on Metastatic Phenotype and Response to Treatment in Osteosarcoma Cell Lines
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-29) Cinnamaldehyde DNA Adducts are Mutagenic and Block Replication
Favorite
10:30 AM – 11:30 AM
ET
(W1030-06-31) Small Scale, Rapid Prototyping of Hydralese™ (PGSU) (poly(glycerol sebacate) urethane) Microdevices for Controlled Drug Delivery in Ocular Implants
Favorite
10:30 AM – 11:30 AM
ET
(W1030-06-32) Probing Microenvironmental Acidity in Pharmaceutical Frozen Solution Using Solid-State NMR Spectroscopy
Favorite
10:30 AM – 11:30 AM
ET
(W1030-06-34) Characterization of Protein Formulations to Optimize Annealing Parameters for Freeze-Drying
Favorite
10:30 AM – 11:30 AM
ET
(W1030-06-35) Impact of Material Attributes on In Vitro Performance of Clindamycin Phosphate Vaginal Creams
Favorite
10:30 AM – 11:30 AM
ET
(W1030-07-37) Production and Optimization of
Nanosac
as a Soft Nanocarrier for siRNA Delivery to Solid Tumors
Favorite
10:30 AM – 11:30 AM
ET
(W1030-07-38) Preparation and Pharmacokinetic Evaluation of Long-Acting Injectable Nanocrystalline Suspension of Montelukast
Favorite
10:30 AM – 11:30 AM
ET
(W1030-07-40) Screening Primary Parameters Affecting Formulation of Hydrogen Sulfide Donors-Loaded Microparticles using Quality-by-Design (QbD) Approach
Favorite
10:30 AM – 11:30 AM
ET
(W1030-07-41) Enhanced Oral Bioavailability of Resveratrol Using Various Formulation Strategies
Favorite
10:30 AM – 11:30 AM
ET
(W1030-07-42) Long-Term Stability Studies of Extemporaneously Compounded Amiloride Nasal Spray
Favorite
10:30 AM – 11:30 AM
ET
(W1030-08-44) Automated and Centralized Buffer Management for Downstream Processing in Biopharmaceutical Manufacture
Favorite
10:30 AM – 11:30 AM
ET
(W1030-08-46) Determination of the Evacuation Time of a Newly Developed Chamber Setup for the Investigation of the Spatial Dust Distribution of Pharmaceutical Powders
Favorite
10:30 AM – 11:30 AM
ET
(W1030-08-47) Influence of the Temperature on Near Infrared (NIR) Spectra Determined with a Novel High Speed Sensor used as a PAT Tool for Monitoring the Tableting Process
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-49) An Evaluation of the Effect of Duplicate- and Single- Well Analyses on Assay Cut Point Calculations and Characterization Experiments in Preclinical Immunogenicity Assays
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-50) Challenges and Solutions for Successful Generation of Anti-Drug Antibody (ADA) Positive Control (PC) for Development of ADA assay for STK-001 in Monkey and Human Serum
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-51) Optimizing ADC Separations: Advantages of Bio-Compatible Versus Stainless Steel UHPLC Systems
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-52) Generation of Rabbit Anti-Peptide Monoclonal Antibodies for Microdystrophin and Dystrophin Quantitation
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-53) Prediction of Frozen Virus Stability Based on Protein Degradation Mechanisms, Real-Time Data of Representative Viruses, and Data Modeling
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-55) Seeking Novel Drug Targets for Anti-Metastasis Treatment
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-57) In Silico Tuning of API for Liposomal Drug Delivery
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-58) Characterization of Selective CYP46A1 Inhibitors and Activators Across Compound Library Using a High-Throughput Screening Platform
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-59) Replication Block and Mutagenicity of Aminofluorene-Guanine Adduct Inepigenetically Modified Sequence Contexts
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-67) Optimization of the In Vitro Skin Permeation of Resveratrol from Microemulsions
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-68) No Pain, Immunity Gain: Pain-Free Dissolving Microneedles as a Vaccine Strategy against Zika
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-69) Optimization of Amorphization Kinetics during Hot Melt Extrusion by Particle Engineering
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-70) A Rheological Approach for Determining Miscibility of Amorphous Solid Dispersions
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-71) Application of Sodium Alginate as Raft-Forming Agent in Anti-reflux Chewable Tablets
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-13) Inhalation Dry Powders of Monoclonal Antibodies Made by Thin-Film Freeze-Drying
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-72) Nanostructured Lipid Carriers Enriched Gel for Enhancing Topical Delivery of Betamethasone Dipropionate in Treatment of Atopic Dermatitis
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-01) Hydrogel-Forming Microneedles in Combination with Risperidone/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Enhanced Transdermal Delivery Potential for the Treatment of Schizophrenia
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-02) Study of Etamsylate Release Kinetics from Controlled Release Matrix Tablets Using the Buffer Transition In Vitro Dissolution Method
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-03) Study of Physiological Buffering Effects on Ezetimibe Supersaturation Using Hydroxypropyl Cellulose as Precipitation Inhibitor
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-04) Identifying the Operating Space and Repeatability of a Novel Filament Free FDM Printer
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-06) Amorphous Chemical Stability of an Oral Tablet Using Moisture-Modified Arrhenius Modeling
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-13) Assessing the Impact of Surface Energy of Probe on Adhesive Properties Using Novel 3D Printing Approach
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-14) Development and Evaluation of a Label Friendly Film Coating System Containing Naturally Derived Opacifier
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-15) Development of Bupivacaine Hydrochloride Mucoadhesive In Situ Forming Gels for Oral Mucositis
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-16) Development of Enhanced the Physicochemical Properties, Solubility, and Oral Bioavailability of Rivaroxaban-Loaded Solid Self-nanoemulsifying Drug Delivery Systems
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-17) Enabling Oral Delivery of Exenatide by Designing Phospholipid Complexes for Self-nanoemulsifying Drug Delivery Systems
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-19) A Novel Solid the Lipid Nanoparticles Formulation with Anti-inflammatory Properties for RNA Delivery
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-21) Fluorescently Labeled P407 Enters Micropores Generated Using Microneedles
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-22) Preparation and Evaluation of Choline Alfoscerate Sustained Release Coated Soft Capsule Using the Controlled Osmotic Pump System
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-23) The Effect of Surfactants and pH Modifying Agents on the Dissolution and Permeation of Pimobendan
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-24) Evaluation of Polymers for Extended-Release Formulations: Hot-Melt Extrusion Paired Fused Deposition Modeling 3D Printing
Favorite
11:30 AM – 12:30 PM
ET
(W1130-05-25) Exploring the Use of Kinetic pH Calculation to Correct the ACAT Model with a Single Stomach Compartment Setting: Impact of Stomach Setting on Food Effect Prediction for Basic Compounds
Favorite
11:30 AM – 12:30 PM
ET
(W1130-05-26) Empty Capsids can Enhance the Transduction Efficiency of AAVs by Inhibiting the Effect of NAbs
Favorite
11:30 AM – 12:30 PM
ET
(W1130-05-27) Engineering and Optimization of 3D Printed Parenteral Implants
Favorite
11:30 AM – 12:30 PM
ET
(W1130-05-28) Polymeric Delivery with Dual Drug Payloads for Hepatocellular Carcinoma (HCC) Therapy
Favorite
11:30 AM – 12:30 PM
ET
(W1130-05-29) Inactivation of Integrated Stress Response Pathway Sensitizes Triple-Negative Breast Cancer Cells to Proteasome Inhibitors
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-31) Evaluating Strategies to Minimize Leakage of Protein from Ethylcellulose Microcapsules Using Bovine Serum Albumin as Model Protein
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-32) In Vitro Model to Study the Lymphatic Voyage of Drugs via Artificial Chylomicrons
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-33) Reducing Degradation of a Ritonavir Amorphous Solid Dispersion by Managing Melt Temperature in a Twin Screw Extruder
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-34) The Influence of Single Peripheral Replacements on the Supramolecular Structures of Sulfonyl Urea Analogues: H vs. CH
3
vs. Cl vs. Br
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-35) Effect of Kneading Disk Geometry on Twin-Screw Continuous Melt Granulation
Favorite
11:30 AM – 12:30 PM
ET
(W1130-07-38) Investigation of Physical Stability of Coamorphous Systems at Elevated Temperature and Humidity Conditions
Favorite
11:30 AM – 12:30 PM
ET
(W1130-07-39) A Solvent Free Thermo-Sensitive Gel Using Bioresorbable Polymers for Sustained Delivery of Biologic APIs
Favorite
11:30 AM – 12:30 PM
ET
(W1130-07-40) Effect of Receptor Medium on Skin Permeability during In Vitro Skin Permeation Test (IVPT) Experiment
Favorite
11:30 AM – 12:30 PM
ET
(W1130-07-41) Comparison of Centrifugation Method and Vacuum Method in Fabricating Microneedles
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-68) High Drug Loading Sustained-Release Metformin HCl Tablets: Hydroxypropyl Methylcellulose (HPMC) Based Semi-solid Extrusion 3D Printing
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-69) Novel Electrospun Nanofiber Buccal Films for Treating Opioid Use Disorder
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-70) Development of a Donepezil Dry Powder Formulation for Enhanced Nasal Mucosa Permeation
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-71) A Preclinical Solution Formulation Development with the Fundamental Understanding of Salt Solubility
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-72) In Vitro Evaluation of an Extended Released Methylphenidate Hydrochloride Product Sprinkled on Food Vehicles
Favorite
12:30 PM – 1:30 PM
ET
(W1230-01-01) Trafficking of Acetalated Dextran Microparticles after Subcutaneous Injection
Favorite
12:30 PM – 1:30 PM
ET
(W1230-01-02) Matrix Metalloproteinase-Responsive Hydrogels for the Treatment of Inflammatory Skin Diseases
Favorite
12:30 PM – 1:30 PM
ET
(W1230-01-05) Early-Stage Polymer Selection in Development of Stable Amorphous Solid Dispersion by Integrating Molecular Dynamics Simulation and Experimental Techniques
Favorite
12:30 PM – 1:30 PM
ET
(W1230-01-06) A Multi-detector Platform Combining Liquid Chromatography with High Resolution Mass Spectrometry, UV and Charged Aerosol Detection for Comprehensive Extractables and Leachables Analysis
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-07) Investigation of the Relationship between Product-Dose and Dermal Exposure of Lidocaine and Prilocaine from a Topical Cream Product Using Dermal Microdialysis
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-09) In Vitro Assessment of Comparative Immunogenicity for Generic Synthetic Peptide Drug Products
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-10) Clinical Ocular Exposure Extrapolation Using PBPK Modeling and Simulation: Gatifloxacin Solution Case Study
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-11) Multiple-Dose Pharmacokinetics of Major Kratom Alkaloid, Mitragynine, in Rats
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-12) Computational Prediction of Drug-Induced Liver Injury with Combination of Convolutional Neural Networks and Multilayer Perceptron
Favorite
12:30 PM – 1:30 PM
ET
(W1230-07-37) Understanding the Effects of Varying Mannitol Concentrations on Inhalable Protein Formulations
Favorite
12:30 PM – 1:30 PM
ET
(W1230-07-38) Transdermal Delivery of Diclofenac Base: Effect of Silicone and Acrylic Pressure Sensitive Adhesive Blends on Drug Delivery and Adhesive Performance
Favorite
12:30 PM – 1:30 PM
ET
(W1230-07-39) Nanocarriers’ Repartitioning of Drugs within the Blood Compartment as a Mechanism of Improving Pharmacokinetics and Efficacy
Favorite
12:30 PM – 1:30 PM
ET
(W1230-07-40) Preparation of Highly Soluble Anti-tubercular Salt: Clofazimine mesylate
Favorite
12:30 PM – 1:30 PM
ET
(W1230-07-41) Solubility Measurement and Modeling of Various Drugs in Binary Solvent Mixtures at Different Temperatures
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-08) In Vitro Comparative Dissolution and Permeation Testing Using the In Vitro Dissolution Absorption System (IDAS) for Expanding Biowaivers to Non Q1/Q2 BCS Class III Products
Favorite
Back to Top
